Custom vaccine aims to stop pancreatic cancer return
NCT ID NCT07612930
First seen Jun 13, 2026 · Last updated Jun 17, 2026 · Updated 1 time
Summary
This program offers a personalized peptide vaccine, PCNAT-01, to eligible patients with pancreatic cancer who have had surgery and completed chemotherapy. The vaccine is designed to train the immune system to recognize and attack leftover cancer cells, potentially lowering the chance of the cancer coming back. It is available only when a clinical trial is not an option, and each vaccine is custom-made for the patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.